Skip to main content

Hyperopia

0
Pipeline Programs
7
Companies
7
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
2 programs
TENEO 317 Model 2 excimer laserN/A1 trial
Technolas 217z Zyoptix LaserN/A1 trial
Active Trials
NCT05264623Active Not Recruiting140Est. Nov 2026
NCT00348205Completed80Est. Mar 2009
Abbott
AbbottABBOTT PARK, IL
1 program
LASIK correction of hyperopic refractive errorsN/A1 trial
Active Trials
NCT01675479Completed167Est. Oct 2016
Carl Zeiss Meditec
1 program
MEL 80 Hyperopic LASIK TreatmentN/A1 trial
Active Trials
NCT00762281Completed189Est. Oct 2008
Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
SpectaclesN/A1 trial
Active Trials
NCT05538182Completed1,883Est. Jul 2023
Bausch + Lomb
Bausch + LombNJ - Bridgewater
1 program
Technolas 217z Zyoptix LaserN/A
Alcon
AlconFORT WORTH, TX
1 program
WaveLight EX500 excimer laser systemN/A1 trial
Active Trials
NCT04805593Completed44Est. May 2023
Glaukos
GlaukosALISO VIEJO, CA
1 program
riboflavin ophthalmic solution, 0% dextranPHASE_1_21 trial
Active Trials
NCT01893359Terminated2Est. Apr 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Glaukosriboflavin ophthalmic solution, 0% dextran
Bausch HealthTENEO 317 Model 2 excimer laser
Mission TherapeuticsSpectacles
AlconWaveLight EX500 excimer laser system
AbbottLASIK correction of hyperopic refractive errors
Bausch HealthTechnolas 217z Zyoptix Laser
Carl Zeiss MeditecMEL 80 Hyperopic LASIK Treatment

Clinical Trials (7)

Total enrollment: 2,505 patients across 7 trials

NCT01893359Glaukosriboflavin ophthalmic solution, 0% dextran

Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic Astigmatism

Start: Aug 2013Est. completion: Apr 20162 patients
Phase 1/2Terminated
NCT05264623Bausch HealthTENEO 317 Model 2 excimer laser

Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without Astigmatism

Start: Nov 2022Est. completion: Nov 2026140 patients
N/AActive Not Recruiting
NCT05538182Mission TherapeuticsSpectacles

Zimbabwe Eyecare And Learning(ZEAL):Formative Research on Hyperopia and Educational Outcomes in Primary School Children

Start: Sep 2022Est. completion: Jul 20231,883 patients
N/ACompleted
NCT04805593AlconWaveLight EX500 excimer laser system

Clinical Investigation of the WaveLight® EX500 Excimer Laser

Start: Apr 2021Est. completion: May 202344 patients
N/ACompleted
NCT01675479AbbottLASIK correction of hyperopic refractive errors

Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refractive Errors

Start: Dec 2012Est. completion: Oct 2016167 patients
N/ACompleted
NCT00348205Bausch HealthTechnolas 217z Zyoptix Laser

A Study to Evaluate the Safety and Effectiveness of the Technols 217z Zyoptix System for Hyperopia

Start: Jun 2005Est. completion: Mar 200980 patients
N/ACompleted
NCT00762281Carl Zeiss MeditecMEL 80 Hyperopic LASIK Treatment

Safety and Effectiveness Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Hyperopia

Start: Jul 2004Est. completion: Oct 2008189 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.